Board at their meeting held on 29.05.2025 interalia approved M/s. ATCS & Associates, Company Secretaries as Secretarial Auditor of the Company for a term of 5 consecutive years from FY ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sunil Healthcare's board met on May 29, 2025 and approved the audited standalone and consolidated financial results for Q4 and the full year ended March 31, 2025. Statutory auditor Singhi & Co. issued an unmodified (clean) opinion on the results. The board has decided not to recommend any dividend for FY2024-25, meaning shareholders will not receive any payout this year. The board appointed M/s. ATCS & Associates as the new Secretarial Auditor for a 5-year term (FY 2025-26 to FY 2029-30), subject to shareholder approval, and also appointed M/s. Agrawal S. Lal & Co. as Internal Auditor for FY 2025-26. Both appointments are routine and based on Audit Committee recommendations.
The clean audit opinion is reassuring for shareholders, but the decision to skip dividend may disappoint income-focused retail investors. Auditor appointments are administrative and have no material impact on stock price.